This list is an analysis based on recent market events. It's not an investment recommendation.
About
Bonraybio Co., Ltd., a development stage company, manufactures medical instruments and solutions for the male infertility market. The company provides LensHooke X12 PRO semen analysis systems; and LensHooke X1 PRO semen quality analyzers. It also provides consumables, such as CS3 semen test slides; CA0/CA1 sperm separation solutions; and CS1 semen test cassettes. In addition, the company provides X QC Reticles, X QC video tools, and X QC beads; sperm DNA fragmentation test kits; and S10 data consolidation software. Bonraybio Co., Ltd. was founded in 2015 and is based in Taichung, Taiwan.
Depending on the exchange, the stock ticker may vary. For instance, on Taiwan OTC Exchange exchange Bonraybio. stocks are traded under the ticker 6955.TWO.
What is Bonraybio. revenue for the last year?▼
Bonraybio. revenue for the last year amounts to 306.31M TWD.
What is Bonraybio. net income for the last year?▼
6955.TWO net income for the last year is 102.51M TWD.
Does Bonraybio. pay dividends?▼
Yes, 6955.TWO dividends are paid annual. The last dividend per share was 1.4 . As of today, Dividend Yield (FWD)% is 0%.
In which sector is Bonraybio. located?▼
Bonraybio. operates in the Other sector.
When did Bonraybio. complete a stock split?▼
The last stock split for Bonraybio. was on August 26, 2026 with a ratio of 1075:1000.